Clinical Trials Logo

Seizure Disorders clinical trials

View clinical trials related to Seizure Disorders.

Filter by:
  • None
  • Page 1

NCT ID: NCT02229318 Completed - Seizure Disorders Clinical Trials

A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet.

FruitiVits
Start date: September 2014
Phase: N/A
Study type: Interventional

Subjects will be asked to substitute their usual vitamin and mineral supplement/s with FruitiVits for seven consecutive days.

NCT ID: NCT01159431 Completed - Epilepsy Clinical Trials

External Trigeminal Nerve Stimulation for Epilepsy

Start date: January 2008
Phase: Phase 2
Study type: Interventional

This study investigates a new therapy for epilepsy called Trigeminal Nerve Stimulation (TNS). TNS involves external electrical stimulation of sensory nerve located above the eyes and over the forehead. The purpose of this study is to determine if TNS is safe and effective using a rigorous randomized active-control clinical trial design in 50 people with epilepsy.

NCT ID: NCT01116700 Completed - Seizure Disorders Clinical Trials

Dexmedetomidine in Seizure Patients

Start date: December 2010
Phase: Phase 1
Study type: Interventional

Dexmedetomidine is an alpha-2 agonist commonly used during neurosurgery due to its unique properties as a sedative and anxiolytic with minimal respiratory depression. Neurosurgical patients frequently come to the operating room on anticonvulsant therapy with a history of seizures. The investigators clinical experience suggests that these patients are resistant to the sedative effects of dexmedetomidine. This effect may represent a pharmacokinetic interaction between the anticonvulsant medications and dexmedetomidine or the higher dexmedetomidine dose requirement could result from abnormal pharmacodynamics due to the underlying seizure disorder. The investigators study aims to investigate the pharmacokinetic and pharmacodynamic differences of dexmedetomidine between patients receiving and not receiving enzyme-inducing anticonvulsant therapy and to identify a potential mechanism for these differences.